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Recent research highlights that patient engagement, conceived as a patient’s behavioral, cognitive and
emotional commitment to his own care management, is a key issue while implementing new technolo-
gies in the healthcare process. Indeed, eHealth interventions may systematically fail when the patient’s
subjective experience has not been taken into consideration since the first steps of the technology design.
In the present contribution, we argue that such an issue is more and more crucial as regarded to the field
of Ambient Intelligence (AmI). Specifically, the exact concept of technologies embedded in the patients’
surrounding environment implies a strong impact on their everyday life, which can be perceived as a lim-
itation to autonomy and privacy, and therefore refused or even openly opposed by the final users. The
present contribution tackles this issue directly, highlighting: (1) a theoretical framework to include
patient engagement in the design of AmI technologies; (2) assessment measures for patient engagement
while developing and testing the effectiveness of AmI prototypes for healthcare. Finally (3) this contribu-
tion provides an overview of the main issues emerging while implementing AmI technologies and sug-
gests specific design solutions to address them.
 2016 Elsevier Inc. All rights reserved.1. Introduction
The aging society is today one of the major concerns for health-
care systems across Western countries because this sociological
phenomenon is increasingly affecting the quality and quantity of
the demand of care. Particularly, the increasing number of individ-
uals suffering from chronic conditions and demanding for long-
term treatments requires to identify sustainable solutions for pro-
viding cost-effective and high-quality care services. For these rea-
sons, this has become part of the priorities’ agenda for both
clinicians and policymakers [1]. The implementation of technolog-
ical solutions aimed at enabling continuity of care by systemati-
cally monitoring the patient along his/her healthcare journey is
today recognized as a possible strategy to face this challenge. At
the time the present contribution is been written, numerous
reviews are available investigating the effectiveness of new tech-
nologies designed to improve assessment and rehabilitation, dis-
ease management, health information retrieval, medical
consultation and treatment adherence [2–5]. Elbert and colleagues
[6], who performed a systematic review of systematic reviews and
meta-analyses, found that 23% of reviews reported positive resultsin terms of effectiveness and cost effectiveness, and other 43% con-
cluded that the research results are appreciable and promising.
Indeed, an important outcome of new technologies used in the
context of healthcare is related to the improved possibility to con-
tinue analyzing and treating patients outside of the medical con-
sultation, making home-based care possible [7,8]. In this sense,
eHealth has proven to be an effective resource to extend care path-
ways from acute to chronic diseases, giving rise to healthcare sce-
narios in which the patient can be potentially assisted at any
moment of his/her personal life. eHealth permits to develop inte-
grated, sustainable and patient-centered services and promote
effective exchanges among the actors involved in the care process
[9].
However, coming closer to the focus of the present contribution,
eHealth has been often considered able to promote patient engage-
ment too [10–13], generally defined as patients’ ability and avail-
ability to have a starring role in their healthcare [14–16]. This is
today considered a key priority for healthcare. Indeed, ‘‘engaged”
patients, or patients who actively participate in managing their
own disease condition, are demonstrated to gain successful clinical
outcomes more than patients who simply adhere to treatments in
a passivizing logic [17,18]. This happens because engaged patients
are more likely than others to enact preventive behaviors,
self-manage their symptoms and treatments, actively seek health
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approaching new patients and promoting peer support [19–22].
However, recent literature [23–25] suggests that patient
engagement is not a direct outcome of eHealth implementation,
rather patient engagement strategy should be considered in
advance when designing the new technologies for healthcare.
Otherwise, there is a widespread agreement about the fact that
without considering the patient as an active agent in the health-
care environment, such solutions risk to be substantially ineffec-
tive in the end. Indeed, despite the rhetoric and trust for eHealth
solutions, patients don’t accept the use of health technologies as
much as they could [26–28]. Indeed, when the personal commit-
ment of patients to the healthcare process is at low levels, informa-
tion technologies-based interventions may fail irrespectively of the
effectiveness and technological advancement of the involved tools
[25]. For example, therapeutic contents administered via comput-
erized programs may lack of implicit emotional aspects which are
fundamental elements for the establishment of a therapeutic alli-
ance [29]. Only supporting this aspect, the patient will be able to
enhance his/her disease management skills and would be more
akin to accept technologies for managing his/her own health and
care.2. The case for Ambient Intelligence
As previously said, a strategic approach to the promotion of
patient engagement is fundamental for the effective implementa-
tion of eHealth-based interventions. However, the web-based tech-
nologies that are usually included under the aegis of eHealth and
related concepts require an active contribution on the patient’s
part. Indeed, patients involved in eHealth interventions typically
interact with dedicated web portals, online social networks, or
mobile apps that help them to enhance their own health literacy,
disease management and the consultation with the health
professionals.
The case with one of the most advanced incarnation of commu-
nication technologies for healthcare, namely Ambient Intelligence, is
quite different. The term Ambient Intelligence refers to monitoring
and assistive technologies embedded in the everyday objects,
which already affect the everyday activities of the target users.
Specifically, the embedding of micro-computers and different
kinds of sensors (pressure/strain, image processing, sound, motion,
physiological signals, . . .) allows a distributed system to recognize,
analyze and monitor people present in the environment and their
activities; then, integrated computational elaboration permits to
understand their needs and to respond accordingly with online
modifications of the environment itself. According to literature
[30–32] an Ambient Intelligence application is recognizable on
the bases of some distinctive characteristics: it is context aware
(it makes use of information drawn on the here-and-now situa-
tion); personalized (it is tailored on the individual user’s needs);
anticipatory (it develops the capacity of predicting user’s needs);
adaptive (it is able to modify its own functions/behavior on the
basis of the user’s habits); ubiquitous (it is embedded and dis-
tributed among the environment); transparent (it is able to func-
tion without direct action, nor perception, nor knowledge by the
human user). Indeed, health is one of the main application fields
for AmI technologies [33], so that Ami (considered in terms of
ubiquitous sensors; pervasive care; artificial intelligence, and
automation) can be considered the gold standard for eHealth pro-
fessionals to achieve [34,35].
However, if we consider the characteristics of AmI as outlined
above (the latter in particular), one could say that patient engage-
ment would be less important in the context of AmI. Indeed, AmI
users can be even unaware that a given technological system isworking around them, analyzing their physiological status and
behaviors in order to automatically-provide assistive outcomes.
In this sense, a chronic patient (or secondary users, such as his
caregivers) could be involved in the AmI implementation process
at the level of authorization only. Then, when the patient is placed
within an intelligent environment, he has nothing to do apart from
behaving as he normally does. Around him, the AmI system will
proceed with its analysis patterns and will provide the pro-
grammed positive/assistive outcomes such as (for instance) facili-
tating tasks by means of online modifications of tools’ affordances
[36,37]; activating alarms in case of detection of health emergen-
cies [38,39]; satisfying anticipated user’s needs because of having
identified habitual behavior [31,40]; and so on.
Actually, this cannot be the whole story when we consider the
complexity of the subjective point of view of the patient/user. Even
if we talk about ‘‘transparent” technologies, that the user does not
interact with for most of the time, at least two obstacles can get in
the way of acceptance and successful implementation. The first
obstacle is related to authorization by the target patient and/or
the caregivers. Authorization to AmI implementation may be given
by patients basing on misconceptions and/or partial representa-
tions of the system and its functioning, resulting in the patient
later opposing usage because of having experienced an impact on
everyday life he had not correctly estimate previously. The second
obstacle, that is strongly related to the first one, regards integra-
tion at the level of everyday life. The implementation of web-
based eHealth tools usually encounters this issue at a significantly
lower level in that the patient is asked to complete tasks that
require limited time (e.g., report medication adherence on the
web platform). On the contrary, AmI refers to a technology that
is potentially omnipresent and observing specific portions of the
environment continuously. From the point of view of the patient,
it is almost impossible to prefigure any possible event/situation
in his everyday life and what will be his own personal reaction
to being monitored without interruption in specific cases. This
makes difficult for the patient to (1) give authorization to more-
or-less complex AmI implementation in his house, without proper
knowledge of what this would mean for his everyday life, and for
peculiar occasions and (2) feel comfortable with AmI working dur-
ing specific situations in which he would like to enjoy privacy,
autonomy, or solitude.
In other words, some aspects related to patients/users should
always be taken into account when designing AmI technologies:
– the patient is not an object of analysis, but a subject with his/
her own perception of AmI itself;
– as a subject, patient is not monolithic; his/her own perception
of AmI can change over time or depending on specific situations;
so can attitudes, behavior and overall acceptance;
– according to literature, the patient assumes different roles in his
own relation with the integral care system over time; these
roles are associated with peculiar needs, objectives and behav-
ioral profiles.
The subsequent sections of the present contribution will
explore these aspects in detail, in order to provide methodolog-
ical and operative guidelines about how to deal with possible
obstacles for AmI effective implementation. Specifically, the next
section will present the construct of patient engagement, outlin-
ing the evolutionary phases of the patient’s healthcare journey,
the associated psychosocial states with peculiar needs and
objectives, along with the presentation of assessment tools able
to capture patient’s healthcare experience. According to the
specific needs emerging from the patient engagement dynamic-
ity, the main issues for AmI technologies implementation will
be outlined. Finally, this contribution will suggest actionable
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tered Design methods.3. Patient engagement: what is and how to measure it
According to the Patient Health Engagement (PHE) Model,
developed by Graffigna and colleagues [41] and to the more recent
advancement in the psychological literature about the patient
active role in healthcare, ‘‘patient engagement” has been defined
as a ‘‘process-like and multi-dimensional experience, resulting
from the conjoint cognitive (think), emotional (feel), and conative
(act) enactment of individuals toward their health management”
[42]. In other words, patient engagement is characterized by three
interlaced aspects: a cognitive/informational aspect (what the
patient knows and how he efficiently navigates across health infor-
mation); a behavioral aspect (what the patient does concerning
his/her disease and treatment management); an emotional aspect
(how the patient feels when living with a disease). The articulation
and the characteristic of these subjective dimensions contribute to
determine how the patient succeeds in adjusting to (and elaborat-
ing) the onset of the disease and new life condition linked to it.
Moreover, this meaning making process deeply affects the quality
of the care experience and the role the patient is able to enact
within the healthcare environment (from more dependent posi-
tions to more autonomous ones). According to the PHE model,
patient engagement develops through four experiential phases
(namely blackout, arousal, adhesion, and eudaimonic project, see
[42]) which describe the process of patients’ adjusting to his/her
disease condition from being totally frozen due to the emotional
disruption related to the diagnosis to a condition featured by hav-
ing re-gained a satisfying balance between the illness condition
and the other life spheres. According to this approach, the dynam-
icity of the patient’s illness experience determines a fluidity of
patients’ needs and expectations along the care process. This is a
crucial aspect that should be carefully considered in order to cus-
tomize technological interventions above all when they occur
within the daily environment of the patient. Indeed, patients
may be differentially engaged in their healthcare according to their
cognitive, emotional and behavioral approach toward the illness
condition. Therefore, in order to develop and implement effective
technological interventions, such devices should consider the
patients’ priorities and sustain their needs. Specifically, patient
engagement studies suggest that the need for dealing with a
chronic condition requires that the patient recovers the ability to
re-adapt to multiple life domains, and finally learns how to realize
his/her own potentialities and resources even in the presence of a
long-life disease condition. As well as the patient engagement level
is recognized to be unstable across time and across the clinical
phases of the illness journey, measuring this aspect becomes more
and more crucial in order to develop technological solutions really
aligned with his/her needs and to assess their effect across time. In
this aim, the scientific community has produced different tools
aimed at measuring the patient ability to engage and be a proactive
subject within the health care environment. These instruments dif-
ferentiate among each other for their main focus in relation to the
different aspect involved in determining patient engagement and
might allow predicting patients’ health risk [43]. For instance, the
Patient Activation Measure, developed by Hibbard and colleagues
[44] is a well-known instrument specifically aimed at assessing
the patient behaviors when approaching his/her healthcare jour-
ney both in term of disease/treatment management and informa-
tion seeking. Another scientifically accredited instrument is the
Altarum Consumer Engagement (ACE) MeasureTM [45] designed to
assess the level of individuals’ involvement in healthcare decisionsand information management. Within the scientific literature, also
the Patient Enablement Instrument [46] has been demonstrated to
be a reliable measure for assessing patients’ ability to understand
the nature of their health condition and effectively cope with their
illness. Recently, the Patient Health Engagement scale (PHE-s) [41]
was developed as a measure of the patients’ subjective experience
of emotionally adjusting to the health condition. The specificity of
this scale lays in the fact that it allows evaluators not only to
assess the actual patient’s attitude toward his/her health condition,
but also to forecast the patient’s risk for disengagement in health
management and thus design preventive targeted intervention
to optimize care pathways and technologies aimed at enabling
them.
All these instruments can be applied along from the design to
the concrete implementation of AmI solutions. These instruments
might constitute a useful compass to orient the planning and deliv-
ery of technological interventions by effectively engaging people in
disease management, keeping in mind a dynamic vision of the
patient engagement experience. For example, in the first phases
of the engagement process, AmI technologies should assist and
scaffold patients – who are in a passive position for what concern
the care process – in monitoring the health parameters and
managing stressful consequences related to the disease onset. In
the adhesion phase, patients should be empowered and supported
in effectively following the medical regimen. Finally, when the
patient is fully engaged (i.e., eudaimonic project phase), the main
aim of technological interventions should be to support self-
determination and the patient’s autonomous choices related to
the priority life goals; specifically, the adequate space should be
left to patient’s initiative, in that he/she is trying to recover life-
projects and re-designing daily habits considering the presence
of the chronic disease he/she has accepted in his/her own everyday
life (see Fig. 1).
Basically, the most important aspect emerging by taking into
account the dynamics of patient engagement is that patient’s prior-
ities, intentions and needs tend to change over time. For this rea-
son, AmI design should be centered on patient’s experience
including the ability to adapt its outcomes not only to basic needs
emerging in habitual situations, but also to the overall user experi-
ence that is intrinsically characterized by dynamicity and
complexity.
Basing on this concept, the next section will include an over-
view of possible issues that may emerge in the experience of
AmI chronic patients users, in order to provide useful research/
design tools to overcome them and increasing the probability of
success for AmI implementations for healthcare.4. Experiential issues in AmI implementation: solutions from
User Centered Design
As previously explained, the patient engagement process high-
lights the inherently dynamic and complex patient’s experience.
AmI designers/engineers should be able to capture those aspects
in order to produce technologies capable of adapting themselves
not only to basic needs, but also to the evolving intentionality of
patients who learn to manage their own health and everyday life
issues over long periods of time.
Considering the evolving contexts related to health manage-
ment and patient engagement, we maintain that some specific
experiential issues related to AmI usage can be outlined in order
to point out design precautions to be included in the AmI projects.
Table 1 features these specific issues with related examples, conse-
quences for implementation effectiveness, and schematic solu-
tions. These are the experiential issues to be taken into account:
Fig. 1. Functions and priorities of AmI across the patient health engagement phases.
Table 1
User experience issues for developing AmI technologies and possible solutions.
User experience
issue for AmI
technologies
Example Consequences Possible solutions from patient engagement and
experience design strategies
Privacy Detection of patient’s movement may reveal location
of secret private property
Patient is stressed because of ‘‘big
brother” effect
User Profiling: AmI design is informed by the
accurate consideration of individual needs
Influence on
behavior
Patient actively avoids to enjoy stimuli that he thinks
may impact on physiological signals
(1) Detrimental effects on patient’s
well-being and (2) the behavior
analyzed is not natural
Contextual Inquiry: AmI design benefits of analysis/
observation of the individual patient’s
environment and related activities
Changes in
patient’s Quality
of Life needs/
priorities
Patient’s needs moved from ‘‘relieve my pain” (first
phases of illness experience) to ‘‘help me to recover
my hobbies” (eudaimonic project)
AmI outcomes are not updated to
users’ emerging priorities
Highly customizable and modular devices: it should
be possible to adapt AmI outcomes to emerging
needs/objectives by the patients
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renowned issue for AmI technologies implementations [47].
As Cook and Colleagues [31] say, almost any form of data gath-
ering about users can be regarded as a potential violation of pri-
vacy. For example, cameras filming users may present privacy
issues for both registration of personal information (e.g., pass-
word digit), and private/embarrassing situations (e.g., nudity).
Solutions have been proposed limiting cameras registration to
information devoted at the sole localization of users in space
obscuring bodies [48], but these do not exclude the possibility
for potential spectators of inferring private information from
videos; for example, the exact location of secret private prop-
erty the user habitually reaches. Indeed, privacy is a multidi-
mensional construct [49,50] which encompasses aspects
related to personal dignity, individual freedom and control over
information. Moreover, consistently with the patient engage-
ment evolutionary phases, also user’s subjective privacy con-
cerns may evolve over time. A patient may passively accept
that his physiological correlates will be monitored at the time
physicians and caregivers are worried for his safety because of
a new diagnosis; but, when the patient is finally learning how
to manage his own health condition and want to recover differ-
ent activities (leisure, personal relationships), such analyses
may suddenly become invasive. In general, it is probably inad-
visable to base AmI projects on absolute/generalized ideas of
privacy rights.
 Influence on Behavior: consider the example above, about a
user who is aware of AmI technologies registering his own loca-
tion and movement inside the house, and who wants to reach a
personal property; he may decide to not do it in order to avoid
the property location being registered. Similarly, a user aware
that wearable devices are monitoring his own physiological
state may decide to not enjoy stimuli (e.g., eating certain foods,
watching emotional movies, . . .) to avoid that physiological
responses will be erroneously elaborated by the monitoring
technologies. Such examples highlight that the presence ofAmI technologies around a patient, independently of his more
or less exact knowledge of their functioning, may lead users
to modify their own behavior because of a ‘‘big brother syn-
drome” [51], namely the negative feeling emerging from the
impression of being observed by technologies. This issue has
two major consequences: first, the user may feel stressed; sec-
ond, the observed behavior will be not natural and maybe scar-
cely informative.
 Changes in Quality of Life Priorities: In addition to sustain
health promotion, AmI technologies should be able to not put-
ting at risk, or better to actively promote, positive quality of life
of their users [52,53]. However, the well-being of a person with
a chronic disease, who has to learn how to deal existentially and
day-by-day with his own disease, could not be conceptualized
as some list of features/requisites to be simply satisfied [54].
Quality of life priorities tend to change over time, especially
in the case of chronic patients. For instance, in the first periods
after receiving the diagnosis (the ‘‘blackout” phase according to
the PHE model), patients may have to deal with depression
symptoms, and could have the necessity of being monitored
also in respect to the emotionally disrupting experience they
are carrying on. Diversely, when patient engagement is at the
highest possible level (i.e., the PHE model’s ‘‘eudaimonic pro-
ject” phase), patients have accepted their chronic disease condi-
tion, and try to recover their ability to manage daily life, re-
defining everyday activity, leisure, personal relationships and
of course the disease management. In such a condition, their
quality of life priorities moved to a general need of recovering
a sense of freedom in their own life, and they deserve to be
helped in goal setting and high level sense making of their per-
sonal life.
These aspects constitute just some of the possible experiential
issues emerging from AmI technologies, which are not adequately
focused on the user subjective experience throughout the health-
care journey. However, such issues may be countered by means
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(UCD) is a type of design whose goal consists in ensuring that no
aspects of the user experience take place in the interaction without
the designer’s knowledge [55]. The only way to achieve this is to
actively involve the user in all the steps of the generation of the pro-
duct, rather than only in the evaluation phase as in the classical
Usability approach [56]. In this sense, the term UCD can be used
when referring to any design process that is deeply influenced by
the engagement of end-users. [57]. In general, the user involve-
ment in the design process goes from a merely-consultative to an
active decision making/participatory role [58].
In order to implement a UCD, the first step is to identify all the
different stakeholders who are involved with the technologies and
who may benefit from their implementation. This entails those
who manually interact whit it, but also those who or are affected
at some level of its products/results [59]. Then, users become
active contributors in every step of the design process.
UCD methods have been already considered in the field of new
technology for healthcare and patient-centered medicine
[24,60,61], even in the field of AmI [62,63]. Indeed, some of these
research methods come to the aid of AmI designers when trying
to overcome issues related to adequate implementation.
 User profiling: users’ needs in terms of privacy and healthcare
management should be accurately understood in order to guide
design decisions. Moreover, such a research process could be
iteratively reproduced at given times, in order to account for
possible changes in patient’s priorities. First, the creation of per-
sonas can come in handy in the first phases of design. Personas
are fictitious, specific, concrete representations of target users
of a given product/technology [64] that designers use as objects
of reference while developing the product features. First intro-
duced by Cooper [65], the creating personas technique became
a widespread tool for UCD. Miaskiewicz and Kozar [66] used a
Delphi methodology to identify benefits of personas for design,
and identified 22 of them, ranging from improved focus on the
target audience, to correct priority setting, and enhanced inno-
vativeness and evaluation. In general, personas may be sharp-
ened over time thanks to the conduction of UCD interviews
with target users [67], devoted to the identification of the actual
needs of the patients at a given time period. In the end, UCD
usually includes user tests such as the ones typical of Usability,
but the first phases entailing user research are to be considered
more important in influencing the product development [55].
 Contextual inquiry [68] consists in an interview of ethnographic
inspiration which should be conducted with the target user in
the expected context of use of the product/technology, the UC
Designer and the interviewee deepening together the (physical
and cultural) obstacles and opportunities for the implementa-
tion. In the case of AmI, preventive contextual inquiries con-
ducted within the environment that is supposed to become
‘‘intelligent” thanks to the technological implementations
(e.g., the patient’s house) could be extraordinarily useful in
order to understand users’ needs but also habits and behaviors.
Indeed, contextual inquiry differs from a typical interview that
is conducted outside of the environment of interest. Being ‘‘con-
textual”, this method allows both the designer and the target
user to observe and notice aspects of everyday activities that
the patient himself could not be able to recall while thinking
of it in abstract terms, and without the specific competences
of the designer who knows which kind of modifications AmI
technologies could cause in the environment.
 Customizable and modular devices should be probably preferred,
in general, for any healthcare AmI design. Since patients’ needs,
intentions and priorities could change over time, and quality of
life requisites could change as well, AmI should be conceived aseasily modifiable in its functioning and constitutive elements.
Doing so, possible unpredictable changes in patients’ needs
can be accounted for in design, in order to provide AmI tech-
nologies that can be (1) customized by users, possibly with little
help from the professionals, accordingly to emerging needs and
changes in habits and (2) really able to adapt themselves even
to more or less sudden transformations in user experience
toward the everyday management of illness and disease.
5. Conclusion and future research challenges
This paper discussed the current issues of building AmI tech-
nologies for promoting effective assisted living interventions. We
have observed the research efforts of building pervasive home-
care environments with advanced Ambient Intelligence, which
promises to provide safe environments for chronic patients in their
own houses. AmI technologies may be a useful instrument to make
patients active health consumers by controlling their own health
status, assisting everyday tasks and activities, monitoring and
enhancing their quality of life.
However, we also foresee some challenges of such solutions: we
discussed that, despite AmI’s undoubtable potentialities, they may
fail in their aims if designers don’t consider the evolving experi-
ence of health engagement the patient goes through. Not taking
into account the dynamicity of the patients’ health needs and
expectations along the care process – indeed – puts at risk the ben-
eficial effect technologies could have on the patients’ health out-
comes. To address these issues, we deem that the use of UCD
methods could help to meet the challenges of building an efficient
and effective AmI system.
Qualitative research may constitute a valuable resource to cap-
ture the complexity of behavioral, cognitive and emotional corre-
lates of chronic patients using prototypes of sophisticated AmI
technologies, in order to provide information about the character-
istics of AmI as subjectively experienced daily: for instance, are
AmI technologies truly transparent? Or, could they be experienced
as omnipresent/intrusive depending on different situations? Could
the assistive ubiquitous technologies be perceived as a dehuman-
ized/artificial figure included in the care process, causing negative
feelings in the patient? Such questions deserve to be properly
investigated in order to identify possible acceptance issues related
to the AmI technologies of the future.
Moreover, customizing technologies on the bases of the patient
engagement position – i.e., to the level of patient’s adaptation to
the disease condition – makes it possible to diversify/tailor the ser-
vice functionalities and to fully explore the potential of the assis-
tive devices, this way providing patients with chances to keep
living actively. As a final suggestion, future research might test
the discussed design methodologies and the customization poten-
tialities in controlled trials aimed at systematically evaluate
engagement-sensitive AmI technologies and their effects on the
patient health outcomes.
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